Chemoradiotherapy Increases the Incidence Rate of Cachexia in Head and Neck Cancer: A Cohort Study
Concurrent chemotherapy is the leading risk factor of treatment-induced cachexia. The results of this study could help clinicians manage this issue adequately and devise solutions to limit its incidence.
Authors
- Tzong‐Ming Shieh (ORCID: https://orcid.org/0000-0003-1759-9120)
- Kuo‐Ting Sun (ORCID: https://orcid.org/0000-0001-7807-6994)
- Yu‐Hsin Tseng (ORCID: https://orcid.org/0000-0002-8166-5690)
- Yin-Hwa Shih
- Nan-Chin Lin
Institutions
- Asia University (TW)
- Kaohsiung Medical University (TW)
- China Medical University (TW)
- Kaohsiung Medical University Chung-Ho Memorial Hospital (TW)
- Chang Bing Show Chwan Memorial Hospital (TW)
- China Medical University Hospital (TW)
Publication Details
- Journal
- Cancer Research and Treatment
- Published
- 2025-10-30
- DOI
- https://doi.org/10.4143/crt.2025.482
- Primary Topic
- Nutrition and Health in Aging
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- China Medical University
- China Medical University, Taiwan
- National Science and Technology Council